Mutations in the pro-opiomelanocortin and melanocortin 4 receptor genes (POMC and MC4R) cause monogenic obesity, and the POMC locus (2p21) has been linked to leptin levels and body mass index (BMI). We searched for monogenic obesity due to mutations in POMC and MC4R among morbidly obese Swedes and studied the association of POMC variants with BMI and serum leptin levels. DESIGN: MC4R and POMC were screened for mutations in 102 obese Swedish subjects (40711 y, 41.375.0 kg/m 2 ) using the single-strand conformation polymorphism technique. The detected polymorphisms were genotyped in 118 lean control subjects (56711 y, 22.671.3 kg/m 2 ) and studied for association with BMI and serum leptin levels. RESULTS: No cases of monogenic obesity due to mutations in POMC or MC4R were identified and none of the four common POMC polymorphisms (RsaI, ins56, Glu188Gly and C8246T) were associated with obesity. Lean carriers of the C8246T CCgenotype had higher serum leptin levels compared to CT or TT carriers (9.776.6 vs 6.774.4 mg/l, P ¼ 0.003 for leptin levels adjusted for age, sex and BMI in regression analysis), especially lean females (P ¼ 0.004) and lean female carriers with the C8246T(CC)/RsaI(ÀÀor +À) genotype combinations (Po0.0005). Neither the C8246T CC-genotype nor the C8246T(CC)/ RsaI(ÀÀor +À) were associated with serum leptin levels in obese subjects. CONCLUSIONS: Monogenic forms of obesity due to mutations in POMC and MC4R are rare in Swedish obese patients. Polymorphisms in POMC are associated with variation in serum leptin levels within the normal range in healthy lean but not in obese individuals.
Introduction
Human obesity can be described as a continuum with monogenic obesity at the one end and obesity entirely due to environmental factors at the other. Most obese individuals seem to cluster in a large intermediate group representing obesity of multifactorial and polygenic etiology. Five different genes causing obesity have been described including leptin (LEP), 1,2 leptin receptor (LEPR), 3 pro-opiomelanocortin (POMC), 4 prohormone convertase-1 (PC1) 5 and melanocortin-4 receptor genes (MC4R). [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] The first four gene defects are extremely rare and only a few cases have been described. [1] [2] [3] [4] [5] In addition to obesity, a varying degree of endocrinological and mental deficiency is manifested in these patients. In contrast, defects in MC4R are more common, the penetrance is not always complete, and individuals with mutations in MC4R usually present with increased lean body mass and liver growth in addition to obesity. Most of the MC4R defects are dominantly inherited, whereas the others clearly show a recessive transmission . [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] The POMC and MC4R gene products are downstream messengers of leptin. Full-length and full-activity leptin receptor is expressed in the hypothalamus, 16 where leptin is an important inducer of POMC expression. 17 POMC codes for a prohormone that is post-translationally processed giving rise to several peptides including adrenocorticotropin (ACTH), beta-lipotropin (b-LPH) and a-, b-and g-melanocyte-stimulating hormones (MSHs). a-MSH acts on the MC4R in the hypothalamus resulting in reduced food intake.
Less is known about genes increasing susceptibility to polygenic obesity. Genome scans have suggested several putative obesity loci, of which the regions on chromosomes 10p, 20q13, Xq24 and 18q21 seem to be the most promising ones. [19] [20] [21] In addition, the POMC locus on chromosome 2p21
has been linked to leptin levels and body mass index (BMI). 19, 22 In Mexican Americans, a haplotype analysis of polymorphisms in 5 0 -UTR (RsaI) and 3 0 -UTR (C8246T) regions of POMC further strengthened this association. 23 However, the C8246T polymorphism was not associated with leptin levels in young healthy individuals with variable BMI 24 or in morbidly obese individuals. 25 Interestingly, the trinucleotide repeat in exon 3 was associated with serum leptin levels in Swedish individuals. 26 The first aim of the present study was to estimate the prevalence of obesity caused by MC4R and POMC mutations among morbidly obese Swedish adults. Second, we investigated if common polymorphisms in POMC are associated with obesity and/or with leptin levels in morbidly obese or lean individuals.
Materials and methods

Subjects
The obese study group consisted of 102 obese individuals from southern Sweden. Due to inadequate weight loss after considerable efforts, this group of patients was undergoing bariatric surgery. 27 These patients had contacted the obesity clinic on their own initiative and were assessed to be well motivated for a weight reduction program. When first contacting the clinic, the patients had a BMI 440 kg/m 2 . The mean BMI of the obese group on the day of surgery was 41.375.0 kg/m 2 (range 30.0-60.2). Information on diabetes and family history of diabetes and obesity were recorded. In total, 118 unrelated lean control subjects were selected from the same geographical region as the obese individuals. They were nondiabetic spouses from a large study of type II diabetes families and were selected based on three criteria. BMI o25 kg/m 2 , age 440 y and no first-degree relatives with type II diabetes mellitus. Of the control individuals, 20 were randomly selected for screening of mutations in the POMC and MC4R, whereas the whole control group was included in the association studies for obesity and leptin levels. The clinical characteristics of the study subjects are shown in Table 1 .
Before participating in the study, informed written voluntary consent was obtained from each subject. The study protocol was approved by the ethics committee of Lund University.
Assays
Serum for analysis of leptin levels was available from 95 (95%) of the obese individuals taken before the bariatric operation and 103 (87%) control subjects. Serum leptin levels were measured after an overnight (12 h) fast using a human leptin radioimmunoassay (RIA) kit (Linco, St Charles, MO, USA). BMI was calculated as weight (kg) divided by height (m 2 ).
Mutation screening
Genomic DNA was extracted from peripheral blood leukocytes. 28 The exonic regions of MC4R and POMC were screened for mutations in overlapping PCR fragments using single-strand conformation polymorphism (SSCP) ( Table 2 ). The MC4R gene was screened for mutations using radioactive SSCP in two different electrophoresis conditions as previously described. 29 When screening POMC, a less laborious real time electrophoresis system was applied with fluorescently labelled (HEX) primers (Gel Scan 2000, Corbett Research, Sydney, Australia). The new method was tested by analyzing 18 earlier identified variations in the GYS2 gene and 94.4% (17 of 18) of the variations were detected with at least one of the new screening conditions. For the GelScan run, the amplified samples were diluted 1:1 with formamide containing 0.025% bromophenol blue and heat denatured for 3 min at 901C. Aliquots (1 ml) of the diluted samples were loaded on two 5% polyacrylamide gels (49:1 acrylamide:polyacrylamide, with or without 2% glycerol) and pulse loaded for 10-20s at 1200 V. Runs were performed at 171C in TBE buffer (71 mM Tris-borate pH 8.3, 1.0 mM EDTA) with constant voltage (1200 V) and analyzed using ONE-Dscan 1.3 software (Scananalytics, Billerica, MA, USA).
Samples showing abnormal migration patterns in SSCP were sequenced bidirectionally using the ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction Kit (PE Biosystems, Foster City, CA, USA), according to the manufacturer's instructions. To promote sequencing of the last four GC-rich fragments of exon 3 of POMC (fragments 3/2-3/ 5, Table 2 ), 5% dimethylsulfoxide (DMSO) was added to the sequencing reaction mixture and the denaturing temperature during amplification cycles was increased from 96 to 981C. Samples were run on an ABI Prism 377 automated DNA Sequencher (PE Biosystems, Foster City, CA, USA) and analyzed using the Sequencher 3.0 program (Gene Codes Corporation, Ann Arbor, USA). Numbering of nucleotides and polymorphisms in this study is based on GenBank accession numbers V01510 and K02406. In two of the earlier publications reporting POMC polymorphisms, a different Pro-opiomelanocortin gene and serum leptin levels Suviolahti et al numbering system has been used. 19, 21 The C8246T polymorphism in the present study is equal to the C7566T polymorphism in these papers.
Localization and genotyping of the RsaI polymorphism in the POMC gene The previously described RsaI polymorphism in the 5 0 -UTR of POMC 30 was genotyped using a less laborious PCR method. A 365 bp genomic fragment containing the RsaI site was amplified with oligonucleotide primers 5 0 -AATGGCCTTTCAGTTCATGGAG and 5 0 -AATTAGGGTCTC-ACTCTGTTGC in a 20 ml volume containing 1 Â ammonium sulfate PCR buffer (67 mM Tris-HCl pH 8.8, 16 mM ammonium sulfate and 0.01% Tween 20), 10 mmol/l each dNTP, 1.5 mmol/l MgCl 2 , 5% DMSO, 0.5 U Taq polymerase (Amersham Pharmacia Biotech in Sweden, Uppsala, Sweden), 10 pmol of each primer and 25 ng genomic DNA. The cycling conditions were 951C for 5 min, 32 cycles of 941C for 30 s, 621C for 30 s and 721C for 30 s followed by final extension at 721C for 10 min. PCR products were digested with 1 U of AfaI (RsaI) (Amersham Pharmacia Biotech in Sweden, Uppsala, Sweden) according to the manufacturer's instructions for 2 h at 371C. The digested products were separated on 3% agarose gels. The RsaI(+) allele was detected as two fragments of 255 and 110 bp, and the RsaI(-) allele as a single 365 bp fragment.
Statistical analysis
Comparison of allele-and genotype combination frequencies between the two groups was performed by the w 2 test and the significance of differences between clinical characteristics was assessed using regression analysis. The ranks of leptin were used as dependent variable in the regression analysis, where age, sex and BMI were included as covariates. The BMDP Statistical Software version 1.12 (BMDP Statistical Software Inc., Los Angeles, CA, USA) or the NCSS Statistical Package (NCSS, Kaysville, Utah, USA) was used for the analysis. Data are shown as mean 7 standard deviation (s.d.). P-values of less than 0.05 were considered statistically significant. Because of the strong correlation between BMI and leptin levels, and due to significant differences between male and female leptin levels, the P-values were not corrected for multiple comparisons. Pro
Results
Clinical characteristics of the study subjects The obese study group consisted of 82 females and 20 males, age ranging from 20 to 66 y and 19% being under 30 y. Of the 102 subjects, 11% had been diagnosed with type II diabetes, 53% had a family history of diabetes and 77% had at least one first-degree relative with obesity. Serum leptin levels of the obese patients and lean controls ranged from 4.4 to 59.5 mg/l and 1.3-27.8 mg/l, respectively. As expected, leptin levels were markedly higher in females, both among lean controls and obese patients, as well as, in obese compared to lean subjects (Table 1) .
Screening of MC4R and POMC We detected two previously known single base pair substitutions in the coding region of MC4R while screening the 102 obese individuals and 20 control individuals, Val103Ile (A700G) and Ile251Leu (A1144C). Both polymorphisms were rare and no significant differences in allele frequencies were observed between the obese and lean groups (Table 3) . Altogether five sequence variations were detected in POMC, all of which have been described earlier. [23] [24] [25] 31 Of these, two were rare silent nucleotide substitutions, C4512T (exon 2) and C7726T (exon 3). The more common variants were a 9 bp insertion [(AGC) 2 (GGC) 1 ] at codon 56 (after nucleotide 7677), an A8021G variant in exon 3 at codon 188 and a C8246T polymorphism in the 3'-UTR region. The 9 b insertion (ins56) is located in the coding region of exon 3 and adds three amino acids, Ser-Ser-Cys, to the 16K peptide, whereas the A8021G variant leads to an amino acid exchange, Glu188Gly, in the b-LPH fragment.
Common POMC polymorphisms RsaI and C8246T Using the POMC exon 1 sequence as a probe (gi 190175, J00290.1), a blast search identified a 178489 bp long human chromosome 2 clone (gi 11342738, RP11-509E16) on which the RsaI site in the 5 0 -UTR could be localized to bp 69219. The rare variants Val103Ile (MC4R), C7726 T (POMC) and C4512 T (POMC) were only genotyped in control individuals included in the mutation screening. All other variants were genotyped in all controls and all variants were genotyped in the obese group.
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The 5 0 UTR RsaI site is thus located 973 bp upstream from another RsaI site in exon 1 and 964 bp from the beginning of exon 1. Using PCR with primers flanking the polymorphic site and restriction enzyme digestion with RsaI, this site was confirmed to be equal to the RsaI site previously detected by Southern blotting. 30 The allele frequencies were 69.1% for the RsaI(+) allele and 84.7% for the C8246T C allele in the control samples. Both variants were in Hardy-Weinberg equilibrium. The RsaI(À) allele was more common in the Swedish population compared to Mexican Americans (30.9 vs 16.0% P ¼ 8 Â 10
À7
). 23 Also, the frequency of the C8246T polymorphism was slightly, but not significantly, higher among Swedish subjects (15.3 vs 11.0%) (P ¼ 0.13) and similar to other European populations (Danish 17.2% and French 18.0%).
24,25
Association between POMC variants, obesity and serum leptin levels The POMC gene variants ins56, Glu188Gly, C8246T and RsaI were genotyped in all study subjects. None of the POMC gene variants were associated with obesity (5.5 vs 3.9%, P ¼ 0.44; 2.5 vs 2.0%, P ¼ 0.68; 15.3 vs 18.6%, P ¼ 0.35; 30.9 vs 31.8%, P ¼ 0.84, for allele frequencies of ins56, Glu188Gly, C8246T and RsaI in control and obese groups, respectively). However, lean carriers of the C8246T CC-genotype had higher serum leptin levels compared to genotype CT or TT carriers (9.776.6 vs 6.774.4 mg/l) with the P-value of 0.003 for leptin levels adjusted for age, sex and BMI in regression analysis. Mostly females contributed to the difference (13.675.8 vs 8.574.4 mg/l, P ¼ 0.004), and the difference was even more pronounced among lean female carriers of the C8246T(CC)/ RsaI(ÀÀor +À) genotype combinations (14.974.5 vs 10.875.7 mg/l, Po0.0005). Correspondingly, allele frequencies of C8246T differed significantly between lean controls with leptin levels above the mean (sex-specific mean) compared to those below (6.1 vs 21.6%, P ¼ 0.0016), particularly among females (3.4 vs 26.7%, P ¼ 0.00050). In contrast, neither the C8246T variant nor the C8246T(CC)/RsaI(ÀÀor +À) genotype combinations were associated with serum leptin levels in obese subjects (32.4712.2 vs 33.7711.9 mg/l, P40.05 and 32.7712.4 vs 33.4711.9 mg/l, P40.05, P-values for leptin levels adjusted for age, sex and BMI in regression analysis). Neither did the allele frequencies of C8246T differ between patients with leptin levels above or below the mean (20.2 vs 16.7%, P40.05). Correspondingly, allele frequency of the C8246T Tallele was similar between controls with leptin levels above the mean and obese patients (21.6 vs 18.6%, P40.05), whereas it was significantly lower among lean controls with leptin levels below the mean compared to obese individuals (6.1 vs 18.6%, P ¼ 0.0047). Table 4 shows the serum leptin levels according to genotypes and genotype combinations in lean and obese Swedish subjects. The frequencies of POMC C8246T/RsaI genotype combinations in Swedes and in Mexican Americans 23 are presented in Table 5 .
Discussion
Herein we describe the screening of POMC and MC4R in morbidly obese patients from Sweden. Common polymorphisms in POMC and MC4R were studied for association with obesity and leptin levels. Among our study group of 102 morbidly obese individuals, no mutations in coding regions of MC4R or POMC associated with obesity were identified. According to previous reports, serum leptin levels in leptin-deficient patients were between 0.7 and 1.6 mg/l 1,2 and in patients with leptin receptor defects between 526 and 670 mg/l. 3 No such extreme leptin levels were observed in our patients, although some of the patients had low leptin levels in relation to their BMI. While the defects in LEP, LEPR and POMC are known to be rare, [1] [2] [3] [4] 24, 31, 35 mutations affecting MC4R function were recently estimated to explain up to 4% of cases with morbid obesity. 11, 12 However, the highest reported prevalences are from studies in which only children or adults with earlyonset obesity have been investigated, whereas studies in obese adults like the present one have repeatedly reported rare or no cases with mutations in the MC4R gene. 10, 31, 32, 34 Indeed, the frequency of obese individuals with functional Pro-opiomelanocortin gene and serum leptin levels Suviolahti et al MC4R mutations has varied from 0 to 6.3% in different studies, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [32] [33] [34] and has been 0.3-6.3% in studies mainly or only on children, [6] [7] [8] [9] 11, 12, 14, 15 while frequencies of 0-0.7% have been reported in studies on mainly obese adults. 10, 13, [32] [33] [34] Hence, our result that none of our patients carried mutations in POMC or MC4R supports the earlier findings that such monogenic forms of obesity are very rare in adult patients. The individual leptin level is an inherited trait with heritability estimates ranging from 0.40 to 0.60. 22, 36 In the present study, combinations of 5 0 -UTR and 3 0 -UTR polymorphisms in POMC were found to be associated with variations in serum leptin levels within the normal range in lean individuals but not in obese. The functional significance of the 5 0 -and 3 0 -UTR polymorphisms of POMC is not known. However, leptin is known to activate POMC neurons 37 and induce POMC expression in the arcuate nucleus in the hypothalamus, 17 where LEPR and POMC are expressed in the same neurons. 38 One explanation for the lack of correlation between the POMC polymorphisms and leptin levels in obese individuals could be a defect in reciprocal regulation of the LEPR and POMC in obese state.
Whether such a defect is of primary genetic origin in the POMC locus or one of the metabolic consequences of adiposity is not known. Although the POMC region on chromosome 2 has shown linkage to serum leptin levels in several populations, 19, 22, 23, 25, 36, 37 mutation screening of POMC has not previously provided any clear explanation for the linkage. 5 0 -UTR (RsaI) and 3 0 -UTR (C8246T) were associated with leptin levels in Mexican Americans 23 and a trinucleotide repeat in exon 3 in Swedes. 26 Association studies in French and Danish populations did not find support for association between leptin levels and POMC. 24, 25 However, there are several differences between the current and the previous studies. First, the latter studies did not include analysis of the RsaI polymorphism. Second, the French study analyzed leptin levels only in the obese sample, and third, the Danish study examined young (18-32 y) individuals with a large variation in BMI (17-42 kg/m 2 ). 24, 25 In contrast, Hixson et al studied POMC haplotypes in the San Antonio Family Heart Study (SAFHS). Similar to our results, association between the genotype combinations of C8246T and RsaI and variation in leptin levels was found in SAFHS. 23 However, the genotype combinations associated with high and low leptin levels did not correspond to the ones in our study. In fact, the genotype combination of 8246(CC) and RsaI(ÀÀ) was reported in association with the lowest leptin levels (25.672.1 mg/l) in SAFHS, while the 8246(TT)/RsaI(++) was associated with the highest leptin levels (45.075.0 mg/l) ( Table 5) . There are several possible explanations for this discrepancy. Firstly, the SAFHS study group represented a mixture of individuals with a large variation in BMI, whereas our study included two extreme groups of BMI. Secondly, our study subjects were unrelated while the SAFHS sample originated from 10 very large families; it can thus be expected that all the individuals with rare genotype combinations were closely related. Finally, significant differences exist in allele frequencies between Swedish and Mexican Americans (30.9 vs 16.0% for RsaI, P ¼ 8 Â 10
À7
). Linkage disequilibrium to other genetic variations important in regulating leptin levels, either in POMC or nearby regions, offers another explanation for differences between our study and the SAFHS study results as linkage disequilibrium can be expected to differ between the two populations.
The other POMC polymorphisms were not associated with BMI or leptin levels. A Glu188Gly mutation has previously been detected in two overweight individuals. 37 Codon 188 is located in the fragment coding for b-lipotropin, the function of which is chiefly unknown. In our study, the Glu188Gly variant was equally frequent in lean and obese individuals indicating no significant contribution to body weight, at least not in the heterozygous state. Mutation screening of MC4R revealed two variants, Val103Ile and Ile251Leu. In agreement with earlier studies, these variants were identified in equal frequencies in obese and lean individuals, thus suggesting no significant contribution to body weight. 8, 12, 38 Neither did a functional study performed on the Val103Ile substitution support any change in MC4R function by this polymorphism. 39 We conclude that monogenic forms of obesity due to mutations in POMC or MC4R are rare in Swedish obese patients. Genetic variation in POMC was associated with variation in leptin levels within the normal range in lean individuals, which emphasizes the link between an adipose tissue signal leptin and the hypothalamic endocrine system as represented by POMC.
